(1R,5S,6S)-6-[1(R)-Hydroxyethyl]-1-methyl-2-[1-(2-thiazolin-2-yl)azetidin-3-ylsulfanyl]-1-carba-2-penem-3-carboxylic acid pivaloyloxymethyl ester
99%
- Product Code: 50670
CAS:
161715-24-8
| Molecular Weight: | 496.64 g./mol | Molecular Formula: | C₂₃H₃₂N₂O₆S₂ |
|---|---|---|---|
| EC Number: | 1308068-626-2 | MDL Number: | MFCD17215369 |
| Melting Point: | 140-142℃ | Boiling Point: | 661.9ºC at 760mmHg |
| Density: | 1.5g/cm3 | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the development of advanced antibiotics, particularly in the treatment of bacterial infections resistant to conventional treatments. Its unique structure allows it to effectively inhibit bacterial cell wall synthesis, making it a potent agent against a wide range of gram-positive and gram-negative bacteria. The compound is often explored in pharmaceutical research for its potential to enhance the efficacy and stability of carbapenem antibiotics. Additionally, its ester form improves oral bioavailability, making it a candidate for oral antibiotic formulations. Research is ongoing to optimize its pharmacokinetic properties and reduce potential side effects, aiming to develop more effective and patient-friendly antibacterial therapies.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | white to beige powder |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿5,410.00 |
+
-
|
| 0.025 | 10-20 days | ฿18,990.00 |
+
-
|
| 0.100 | 10-20 days | ฿55,990.00 |
+
-
|
(1R,5S,6S)-6-[1(R)-Hydroxyethyl]-1-methyl-2-[1-(2-thiazolin-2-yl)azetidin-3-ylsulfanyl]-1-carba-2-penem-3-carboxylic acid pivaloyloxymethyl ester
This compound is primarily utilized in the development of advanced antibiotics, particularly in the treatment of bacterial infections resistant to conventional treatments. Its unique structure allows it to effectively inhibit bacterial cell wall synthesis, making it a potent agent against a wide range of gram-positive and gram-negative bacteria. The compound is often explored in pharmaceutical research for its potential to enhance the efficacy and stability of carbapenem antibiotics. Additionally, its ester form improves oral bioavailability, making it a candidate for oral antibiotic formulations. Research is ongoing to optimize its pharmacokinetic properties and reduce potential side effects, aiming to develop more effective and patient-friendly antibacterial therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :